IDT Acquires GenBase to Establish New Oligo Production Capability
News Dec 16, 2005
The acquisition, which results in the establishment of a new IDT West Coast Operations division, gives the company an immediate, locally based, next-day oligo production capability in the heart of the California biotech industry, as well as access to GenBase's local knowledge and industry experience.
"Researchers everywhere are under pressure to produce results quickly, and they know that IDT represents the best in oligo synthesis, quality assurance, and customer support," noted Trey Martin, chief operating officer of Integrated DNA Technologies, Inc.
"Now we're bringing that quality standard and QC to the next-day service sector at the heart of California's important oligo market."
"GenBase's success in serving organizations for the last eight years played a central role in the development of this deal," said Jun Wang, founder and CEO of GenBase, Inc.
"We share IDT's commitment to the customer, and to the Life Sciences industry, and look forward to adding our experience, and ideas to theirs."
Heading IDT's West Coast Operations in San Diego will be general manager Dan Dernbach, an eight year veteran at IDT.
GenBase's Jun Wang will remain as IDT's vice-president of international sales, with a focus on the Pacific Rim.
The new facility will use Integrated DNA Technologies' in-house nucleic acid synthesis technologies and processes, and will begin oligonucleotide production in late December 2005.
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE
Hidden Signals in RNAs Regulate Protein SynthesisNews
Scientists have long known that RNA encodes instructions to make proteins. In a new study published in Nature, scientists describe how the protein-making machinery identifies alternative initiation sites from which to start protein synthesis.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.